| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.76B | +9.8% |
| Cost of Revenue | $572.6M | +6.8% |
| Gross Profit | $2.19B | +10.6% |
| R&D Expense | $539.5M | +12.3% |
| SG&A Expense | $419.6M | +32.7% |
| Operating Income | $31.6M | +135.9% |
| Interest Expense | $6.8M | +7.1% |
| Pre-tax Income | $93.7M | +204.2% |
| Income Tax | $19.7M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $797.1M | +10.4% |
| Accounts Receivable | $439.3M | -15.0% |
| Current Assets | $1.57B | -3.9% |
| Total Assets | $2.97B | -1.4% |
| Current Liabilities | $1.66B | -24.8% |
| Total Liabilities | $1.84B | -23.1% |
| Stockholders' Equity | $1.13B | +83.0% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $979.5M | +93.3% |
| Capital Expenditures | $92.4M | +19.0% |
| Investing Cash Flow | $44.6M | +123.3% |
| Financing Cash Flow | -$946.0M | -862.8% |
| Free Cash Flow | $887.1M | +106.7% |
| +160.1% |
| Net Income | $74.0M | +175.9% |
| EPS (Basic) | $0.36 | +173.5% |
| EPS (Diluted) | $0.36 | +173.5% |